Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Use of Varenicline for 4-weeks Prior to Quitting [Phase 3]
A Phase 3 trial evaluated starting varenicline four weeks before quitting smoking, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Exercise to Enhance Smoking Cessation for Women at the YMCA [Phase 2, Phase 3]
Phase 2/Phase 3 trial update on using exercise to enhance smoking cessation in women at the YMCA; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Increasing Contingency Management Success in Smoking Cessation [NA]
Completed clinical trial evaluating contingency management to improve smoking cessation; results posted in 2012.
-
FDA approval · 2012-05-23FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers [Phase 3]
This update reports a comparability study comparing the Phase 3 production lot and a single commercial lot of NicVAX in healthy adult smoker…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: Antibody and Safety Study of 6 Doses of NicVAX in Smokers [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating six doses of NicVAX, Nabi Biopharmaceuticals' nicotine vaccine, i…
-
CLINICAL_TRIALS trial_result · 2012-05-09Clinical Trial Update: NicVAX/Placebo as an Aid for Smoking Cessation [Phase 3]
Phase 3 trial evaluating NicVAX (vaccine) vs placebo for smoking cessation has completed.
-
CLINICAL_TRIALS research · 2012-05-09Clinical Trial Update: Pharmacoeconomic Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies [Phase 3]
This document reports pharmacoeconomic analyses for Nabi-4514 and Nabi-4515 in Phase 3 smoking cessation trials.
-
CLINICAL_TRIALS research · 2012-05-02Clinical Trial Update: Tobacco Use Intervention Among Radiation Oncology Patients [Phase 2]
This Phase 2 clinical trial tests a tobacco use intervention among radiation oncology patients and the study status is completed.
-
CLINICAL_TRIALS research · 2012-05-02Clinical Trial Update: Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers [NA]
This clinical trial update describes a study evaluating whether an intensive behavioral training program can reduce impulsivity and improve …
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls [Phase 2]
Phase 2 clinical trial update evaluating smoking abstinence and lapse effects in smokers with schizophrenia and in control participants; the…
-
FDA approval · 2012-04-25FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) submitted by Strategic Sourcing Services LLC.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: Smoking Reduction or Cessation With Nicotine Replacement Therapy [Phase 3]
Phase 3 trial update reports completion of a study evaluating nicotine replacement therapy for smoking cessation. The snippet does not speci…
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers. [NA]
This is a clinical trial update describing a brain imaging study of nicotine-induced dopamine release in cigarette smokers; the status is un…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Effectiveness of Pedialink CEASE Module [NA]
A completed clinical trial evaluated the Pedialink CEASE Module for tobacco use disorder.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo [NA]
A terminated Mayo Clinic clinical trial comparing varenicline to placebo examined endothelial function and autonomic regulation after short-…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum [Phase 2]
A Phase 2 clinical trial sponsored by the British Columbia Cancer Agency evaluated whether green tea extract can prevent cancer in former an…
-
CLINICAL_TRIALS research · 2012-03-09Clinical Trial Update: Screening Methods in Finding Lung Cancer Early in Current or Former Smokers [NA]
An update on screening methods to detect lung cancer early in current or former smokers, sponsored by the British Columbia Cancer Agency.
-
CLINICAL_TRIALS trial_result · 2012-03-02Clinical Trial Update: Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail [Phase 1, Phase 2]
Phase 1/2 pharmacological trial assessing social cognition, attentional networks, and nicotine dependence in individuals with tobacco use di…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Tobacco Zero: Interactive Tobacco Education for Teens [Phase 2]
Phase 2 clinical trial of the Tobacco Zero interactive tobacco-education program for teens has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) [Phase 3]
Phase 3 trial updates the efficacy and safety of dianicline as an aid to smoking cessation in cigarette smokers; study status is completed.
-
FDA approval · 2012-02-15FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Quitline Use in Surgical Patients [NA]
The Mayo Clinic-sponsored study evaluating the use of quitline support for tobacco dependence in surgical patients has completed. The clinic…
-
FDA approval · 2012-02-01FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application to allow Lil' Drug Store Products, Inc. to market Nicorette 4 mg Fruit Chill Gum (nicotine polac…
-
FDA approval · 2012-02-01FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.